Financials
Financial year 2025
LVL MEDIPHAR from Deinze, company number BE0862946642, closed financial year 2025 with a result of € 81,760 after tax. For that financial year LVL MEDIPHAR recorded a gross margin of € 124,150 and equity of € 528,164. Compared with financial year 2024, the result moved from € 96,824 to € 81,760. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 31, 2025.
€ 528,164
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 81,760
▼ 16% vs 2024
Profit after tax over the fiscal year.
€ 81,985
▲ 207% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 61,963 paid out
76 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 9,098
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 5,158
▲ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 1,571
▼ 30% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,617
▼ 68% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 156,312 | € 108,980 | € 167,357 | € 124,150 | ▼ 26% |
| Profit after taxes | € 80,899 | € 50,389 | € 96,824 | € 81,760 | ▼ 16% |
| Equity | € 442,787 | € 492,376 | € 508,367 | € 528,164 | ▲ 4% |
| Total debts | € 69,425 | € 25,770 | € 62,899 | € 60,450 | ▼ 4% |
| Cash | € 128,306 | € 69,936 | € 26,720 | € 81,985 | ▲ 207% |
| Land & buildings | € 144,131 | € 133,603 | € 123,388 | € 113,306 | ▼ 8% |
| Retained profit | € 424,187 | € 473,776 | € 489,767 | € 509,564 | ▲ 4% |
| Dividend | € 25,800 | € 800 | € 80,833 | € 61,963 | ▼ 23% |
| Bank debt | € 28,533 | € 5,663 | € 5,120 | € 5,158 | ▲ 1% |
| Balance sheet total | € 512,213 | € 518,146 | € 571,266 | € 588,615 | ▲ 3% |
By gross margin, LVL MEDIPHAR ranks 42nd of 107 companies with main activity “Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies” in Deinze that publish figures (fiscal year 2025).
Key figures of LVL MEDIPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about LVL MEDIPHAR the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to LVL MEDIPHAR?
What happened at LVL MEDIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 81,760 (▼ 16% vs 2024). Source: NBB ↗
- New establishment in Deinze. KBO
- Start of the company according to the CBE. KBO
In short
From € 80,899 profit in 2022 to € 81,760 profit in 2025.
Paid € 126,757 in corporate taxes since 2022.
Best year ever: 2024, with € 96,824 profit.
Paid out € 169,396 in dividends to the owners in total.
Management
Behind LVL MEDIPHAR is Lieven Van Landuyt.
Directors
According to the 2025 annual accounts
Lieven Van Landuyt
Director
Establishments
Establishment units
Physical locations of this company
Scheurestraat 7
9850 Deinze
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Deinze
Same main activity (Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies), 153 active companies in Deinze, largest first.
€ 2.6 million gross margin · 2025
€ 2 million gross margin · 2026
€ 1.4 million gross margin · 2025
€ 1.1 million gross margin · 2026
€ 912,244 gross margin · 2025
€ 714,689 revenue · 2025
Details
- Company number
- 0862.946.642
- VAT number
- BE 0862.946.642
- Registered office
- Scheurestraat 7, 9850 Deinze
- Names & denominations
- LVL MEDIPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 January 2004
- Peppol
- Active · Active since 30 Sept 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering